Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Litfulo(Ritlecitinib Tosylate)Pfizer Inc. logoPFE

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Pfizer Inc.

$5.1M

Medicare cost, 2024

Medicare drug plans spent $5.1 million on Litfulo (ritlecitinib tosylate) in 2024, for 1,155 prescriptions and refills filled by 274 patients. Spending rose 2193% from 2023 to 2024. At about $4,441 per prescription it is a high-cost drug. California accounts for the most spending ($438,466, 9% of the total).

Medicare cost, 2024

$5.1M

+2192.5% from 2023

Prescriptions

1,155

$4,441.02 per claim

Patients

274

268 prescribers

Total spending, 2024

$5.1M

$18,720.36 per patient

Questions and answers

How much does Medicare spend on Litfulo?

Medicare prescription drug plans paid $5.1M for Litfulo in 2024, for 1,155 prescriptions and refills to 274 patients (up 2192.5% from 2023). The average cost per claim was $4,441.02.

Which state spends the most on Litfulo?

California had the highest Medicare cost for Litfulo in 2024: $438K for 104 claims, followed by Florida ($422K).

Who prescribes Litfulo the most?

Vaughan C Graves, dermatology in Phila, PA, had the highest Medicare cost for Litfulo in 2024: 34 claims costing $126K.

Who makes Litfulo?

Litfulo is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Litfulo was $5.1M in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Litfulo, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Vaughan C Graves Phila, PADermatology34Under 11$126K
Joel E Perdomo Slidell, LAGeneral Practice27Under 11$102K
Teerawit Supakorndej Mill Creek, WADermatology17Under 11$68K
Polina V Rzepka Twinsburg, OHDermatology14Under 11$56K
Kevin McMullen Missoula, MTDermatology14Under 11$56K
Catherine B Marcum Lakeland, FLDermatology14Under 11$54K
Michael J Spezia Saint Louis, MOFamily Practice14Under 11$53K
Stephanie Gonzales Albuquerque, NMPhysician Assistant13Under 11$53K
Brian L Hunter Harold, KYPhysician Assistant13Under 11$51K
Mona Olive Athens, ALNurse Practitioner13Under 11$51K
Jeremy S Davidson Asheville, NCPhysician Assistant13Under 11$51K
Darin T Smith Tooele, UTPhysician Assistant12Under 11$49K
Jack P Murphy La Place, LADermatology12Under 11$48K
Malik C Spady Covington, LARheumatology13Under 11$47K
Jessica Rodriguez Palm City, FLNurse Practitioner12Under 11$47K
Kristina M Dela Rosa San Diego, CADermatology12Under 11$47K
Dylan Irish Mesa, AZPhysician Assistant12Under 11$45K
Gary B Klein Valencia, CADermatology11Under 11$44K
Susan Decoste Weymouth, MADermatology12Under 11$43K
Anthony E Oro Stanford, CADermatology11Under 11$43K
Francisco Flores Miramar, FLDermatology11Under 11$43K
Kristina Campton Tarrytown, NYDermatology11Under 11$43K
Michael Goldenberg Ashland, KYStudent in an Organized Health Care Education/Training Program11Under 11$43K
James E Cooksey Meridian, MSNurse Practitioner11Under 11$42K
Brian R Sperber Colorado Springs, CODermatology11Under 11$42K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2023254826$224K
20242681,155274$5.1M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Pfizer US PharmPFE logoPFE1,155$5.1M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube